Diagnostic hapten-carrier conjugates BSA-Reverse triiodothyronine (rT3), OVA-Reverse triiodothyronine (rT3), KLH-Reverse triiodothyronine (rT3) for Thyroid diseaserT3detection in Competitive immunoassay validation (Competitive ELISA), Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Product Details
Aldosterone is the main mineralocorticoid steroid hormone produced by the zona glomerulosa of the adrenal cortex in the adrenal gland. It is essential for sodium conservation in the kidney, salivary glands, sweat glands, and colon. It plays a central role in the homeostatic regulation of blood pressure, plasma sodium (Na+), and potassium (K+) levels.Genemedi produces core diagnostic ingredients for test of Thyroid disease and related syndrome.
GeneMedi offers Diagnostic hapten-carrier conjugates BSA-Reverse triiodothyronine (rT3), OVA-Reverse triiodothyronine (rT3), KLH-Reverse triiodothyronine (rT3) for Thyroid disease rT3 detection in Competitive immunoassay validation (Competitive ELISA), Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Thyroid disease test are suitable for in functional ELISA, and other immunoassays in dignostics.
Product Description
|
Cat No.
|
GMP-SMT-rT3-Ag-Ab
|
|
Product Name
|
BSA-Reverse triiodothyronine (rT3) / OVA-Reverse triiodothyronine (rT3)
|
|
Expression platform
|
Synthetic
|
|
Bioactivity validation
|
Reverse triiodothyronine (rT3) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in rT3 level test of Thyroid diseases (stress ) and related syndrome evaluation
|
|
Products description
|
Competitive immunoassay-validated hapten-carrier conjugates BSA-Reverse triiodothyronine (rT3) / OVA-Reverse triiodothyronine (rT3) is Synthetic.
|
|
Purity
|
|
|
Application
|
Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
|
|
Formulation
|
Lyophilized from sterile PBS, PH 7.4
|
|
Storage
|
Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
|
|
Cat No.
|
GMP-SMT-rT3-Ag-Ab
|
|
Product Name
|
Anti-human Reverse triiodothyronine (rT3) mouse monoclonal antibody (mAb)
|
|
Expression platform
|
Hybridoma
|
|
Isotypes
|
Mouse IgG
|
|
Bioactivity validation
|
Reverse triiodothyronine (rT3) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Reverse triiodothyronine (rT3) antibodies in rT3 level test of Thyroid diseases (stress) and related syndrome evaluation.
|
|
Tag
|
mFc
|
|
Products description
|
Anti-human Reverse triiodothyronine (rT3) mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology.
|
|
Specics
|
mouse
|
|
Purity
|
Purity: ≥95% （SDS-PAGE）
|
|
Application
|
Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
|
|
Formulation
|
Lyophilized from sterile PBS, PH 7.4
|
|
Storage
|
Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
|
Diagnostic antibodies and antigens for Epilepsy-related valproate (VPA) toxicity testing: Sodium valproate (VPA)
Valproate is a commonly used antiepileptic drug for the treatment of epilepsy and seizures. It is safe for use in both adults and children more than three years of age. Valproate toxicity can occur both accidentally and intentionally. Acute valproate overdose usually presents with CNS depression/encephalopathy, electrolyte abnormalities such as hypernatremia, elevated transaminase levels, hyperammonemia, and hepatoxicity. In patients with a severe overdose of valproate, patients can present with hypotension, tachycardia, respiratory depression, metabolic acidosis, cerebral edema, and valproate-related hyperammonemic encephalopathy which may progress to coma and death. GENEMEDI developed the Gastrin-17 (G-17) antigens and antibodies for the diagnosis of valproate toxicity based on ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
